We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Quidel Introduces Savanna True Sample-to-Result Multiplex RT-PCR System at ECCMID 2022

By LabMedica International staff writers
Posted on 22 Apr 2022

Image: Savanna is a multiplex real-time PCR testing platform with simple sample-to-result operation (Photo courtesy of Quidel)

Image: Savanna is a multiplex real-time PCR testing platform with simple sample-to-result operation (Photo courtesy of Quidel)

Quidel (San Diego, CA, USA) introduced the Savanna true sample-to-result multiplex RT-PCR system at ECCMID 2022 which took place for the first time as a hybrid event both online and on-site in Lisbon, Portugal on 23 - 26 April 2022. ESCMID's yearly congress attracts over 14,000 participants. This year, the congress featured a hybrid format to facilitate an onsite and online experience for attendees allowing for remote and face-to-face opportunities to take part in the multifaceted program.

Savanna is a multiplex molecular platform that enables professional customers to analyze up to 12 pathogens or targets, plus controls, from a single assay run in less than 30 minutes. The Savanna system is a fully integrated, sample-to-result automated in-vitro diagnostic platform that performs real-time Polymerization Chain Reaction (PCR) tests by using the Savanna instrument and Savanna assay cartridges. After inserting the assay cartridge, the instrument performs sample and reagent preparation, nucleic acid extraction and amplification, real-time detection of RNA or DNA target sequence, and qualitative or quantitative result interpretation from a variety of sample types. The Savanna system is intended to aid in the diagnosis of related diseases. Quidel has received the CE Mark for its Savanna multiplex molecular analyzer, allowing the company to market and sell the Savanna system in Europe, as well as other countries that accept the CE Mark.

“The Savanna system’s small footprint features integrated sample prep combined with rapid real-time PCR amplification and detection technologies, making it a perfect fit for syndromic testing in hospitals and moderate-complexity labs, with the goal of eventually accessing physician offices, urgent care clinics and other point-of-care locations,” said Douglas Bryant, president and CEO of Quidel Corporation.

Related Links:
Quidel

Visit expo >

Platinum Member

Automated Coagulation Analyzer

Hemolumi H6

Gold Member

Quantitative POC Immunoassay Analyzer

EASY READER+

New

Drug Testing Assays

Atellica DT 250 Analyzer

POC Immunoassay Analyzer

Procise DX

Latest ECCMID 2022 News

Channels

Clinical Chemistry

view channel

International Consensus Guidance Outlines General Population Screening for Early-Stage Type 1 Diabetes

Type 1 diabetes (T1D) is an autoimmune disease that can develop in childhood or adulthood and affects an estimated 9.5 million people worldwide. Its complications range from acute diabetic ketoacidosis... Read more

Algorithm Uses Blood Biomarkers to Improve Alzheimer’s Trial Screening

Alzheimer’s disease is a progressive neurodegenerative disorder that causes memory loss and functional decline. Screening cognitively healthy adults for prevention trials is slow and costly because many... Read more

Electrical Fingerprint of Extracellular Vesicles Could Detect Pancreatic Cancer

Pancreatic cancer is often diagnosed only after it has spread, contributing to a five-year survival rate of 13%. Standard blood-based analyses can struggle to distinguish tumor signals from the background... Read more

Image Credit: 123RF

Blood Biomarker May Track Bone Metastases in Medullary Thyroid Cancer

Medullary thyroid cancer (MTC) is a rare malignancy that often progresses silently, frequently going undetected until it reaches advanced stages. By the time it spreads to bone, it can produce unusual... Read more

Molecular Diagnostics

view channel

Image: Blood protein levels can reveal whether genetic variants have biological effects, potentially offering a more scalable, noninvasive way to obtain additional patient information (Image Credit: 123RF)

Blood Protein Analysis Helps Interpret Uncertain Rare Disease Variants

Many patients with suspected rare genetic conditions remain undiagnosed even after genome or exome sequencing, leaving clinicians with limited evidence to interpret uncertain variants. Variants of uncertain... Read more

40-Gene Test Validated for High-Risk Squamous Cell Carcinoma

High-risk cutaneous squamous cell carcinoma (SCC) requires accurate stratification to align surveillance and adjuvant therapy with each patient’s risk. Clinicopathologic staging alone may not precisely... Read more

Image: New findings identify common genetic variants are associated with faster motor decline in Parkinson’s disease (Image Credit: 123RF)

Common Genetic Marker Predicts Faster Motor Decline in Parkinson’s Disease

Parkinson’s disease is a progressive neurodegenerative disorder, but rates of motor decline vary widely among patients, complicating prognosis and clinical trial design. Clinicians have few scalable tools... Read more

Blood Test Helps Clarify Prostate Cancer Risk After Elevated PSA

Prostate cancer screening often begins with prostate-specific antigen (PSA) testing, but elevated results can also occur in benign conditions, creating uncertainty and sometimes leading to invasive procedures.... Read more

Hematology

view channel

Image: New findings indicate that people with borderline anemia—hemoglobin just above WHO anemia thresholds—face a higher mortality risk than those with higher hemoglobin levels within the normal range (Image Credit: 123RF)

Borderline Anemia May Carry Higher Risk Than Current Thresholds Suggest

Hemoglobin concentration is among the most frequently ordered blood tests in primary and hospital care. In older adults, both high and low values have been linked to adverse outcomes, including cognitive... Read more

Biomarker-Guided Framework Aims to Guide Mantle Cell Lymphoma Therapy

Mantle cell lymphoma can follow widely variable courses, from indolent disease to rapidly progressive cancer, complicating initial treatment selection. Many therapeutic decisions still rely on patient... Read more

New Genetic Findings Reveal Cause of Bone Marrow Failure Syndrome

Inherited bone marrow failure syndromes (IBMFS) impair the bone marrow’s ability to produce sufficient healthy blood cells and are associated with an increased risk of early-onset myelodysplastic syndromes (MDS).... Read more

Ultra-Portable Device Enables Finger-Prick Blood Testing at Home

Patients who need frequent blood tests often face repeated clinic visits that burden services and disrupt care. In the UK, millions of tests are performed each year to diagnose disease, guide therapy,... Read more

Immunology

view channel

Image Credit: Adobe Stock

New Cellular Map May Help Predict Crohn’s Disease Course in Children

Crohn’s disease in children is a common and debilitating form of inflammatory bowel disease, marked by chronic intestinal inflammation and limited pediatric-specific treatments. Clinicians must decide... Read more

Image Credit: Adobe Stock

Temporal Immune Profiling Reveals How Sepsis States Change Over Time

Sepsis is a life-threatening condition in which the immune response to infection becomes dysregulated, leading to rapid organ failure and death. Although antimicrobials and organ support remain standard... Read more

Study Identifies Immune Cells That Drive Harmful Autoantibody Responses in COVID-19

Autoantibodies that mistakenly attack the body’s own tissues have been linked to severe COVID-19, Long COVID, and increased risk of autoimmune disease. However, the origins of these autoantibodies during... Read more

Gut “Memory” May Explain Why IBD Flares Return

Inflammatory bowel diseases (IBD), including Crohn’s disease and ulcerative colitis, are characterized by recurring flare-ups that damage the intestinal mucosa and remain difficult to predict.... Read more

Microbiology

view channel

Research Strengthens Bundibugyo Virus Outbreak Readiness with Faster Diagnostics

Bundibugyo virus (BDBV), a species of ebolavirus, causes severe hemorrhagic disease and can be difficult to diagnose rapidly during outbreaks. Recent regulatory changes have further complicated swift deployment... Read more

Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more

Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Genetic Marker Identifies Emerging Resistance to Frontline Malaria Drugs

Artemisinin-based combination therapy remains central to controlling Plasmodium falciparum malaria, but emerging drug resistance is complicating treatment and surveillance. In Uganda and across sub-Saharan... Read more

Pathology

view channel

Image: The workflow analyzes slides already generated during routine care, providing added prognostic information without requiring another tissue test (Image Credit: Shutterstock)

AI Spatial Analysis of Routine Slides Helps Predict Pancreatic Cancer Recurrence

Predicting which patients with pancreatic cancer will recur after treatment and surgery remains challenging. Pathology evaluation typically measures residual tumor burden, but recent work found that tumor... Read more

Hybrid Computational Imaging Method Improves Digital Pathology Resolution

Digital pathology depends on high-resolution whole-slide imaging to capture diagnostically relevant cellular and tissue features, yet conventional methods often force trade-offs between speed, cost, and detail.... Read more

FDA Clearance Expands Digital Pathology Options for Clinical Laboratories

Hamamatsu Photonics K.K. (Hamamatsu, Japan) announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the NanoZoomer S20MD and NanoZoomer S540MD slide scanner systems.... Read more

Label-Free Imaging Reveals Hidden Immune Activity in Blood Samples

Peripheral blood mononuclear cells (PBMCs) are widely used to monitor infection, autoimmunity, cancer, and treatment response, yet most assays depend on fluorescent labels that can perturb cells and provide... Read more

Technology

view channel

New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling

Laboratories often need centrifugation that accommodates multiple vessel formats while maintaining controlled temperatures to protect sensitive samples. Intuitive controls and repeatable operation can... Read more

Bacterial Vesicle Expression System Streamlines Production of Cancer Diagnostic Proteins

Recombinant proteins are central to many cancer diagnostics and therapies, but numerous targets remain difficult and costly to produce because they are unstable, toxic to microbial hosts, or require precise folding.... Read more

Autonomous Robotic System Receives FDA Authorization for Blood Collection

Venipuncture is central to many diagnostic pathways, but routine blood collection can be affected by staffing constraints and procedural variability that influence consistency and patient experience.... Read more

Interoperable Data Platform Standardizes Multi-Cancer Blood Test Results

Proteotype Diagnostics has introduced Alchemi, a proprietary data and clinical workflow platform being developed for Enlighten, the company’s investigational blood-based multi-cancer test.... Read more

Industry

view channel

Sysmex and Cytek Collaboration Expands Access to Advanced Clinical Flow Cytometry

Sysmex Europe SE (Hamburg, Germany) and Cytek Biosciences (Fremont, CA, USA) are partnering across more than a dozen European countries to expand access to advanced clinical flow cytometry.... Read more

Health Canada Licenses Point-of-Care Hematology Analyzer for Decentralized CBC Testing

PixCell Medical’s HemoScreen point‑of‑care hematology analyzer received a Health Canada Class III Medical Device License and will be distributed nationwide through Inter Medico. The authorization follows... Read more

New NHS Partnership Expands Access to Epigenetic CNS Tumor Classifiers

Rapid and accurate classification of central nervous system tumors remains a challenge, particularly in children where histology alone can misclassify aggressiveness and drive overtreatment.... Read more

Fujirebio Expands Access to Automated Blood-Based Neurology Testing in Canada

H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio announced that Health Canada has issued Class II Medical Device Licenses for Lumipulse G NfL Blood and Lumipulse G pTau 217 Plasma for... Read more